关于 "Reverse Transcriptase" 的结果5 个结果
筛选:COX×
- N-(3-pyridyl)-Indomethacin amideCAS: 261766-29-4
Potent and selective reversible inhibitor of COX-2
COX - Revaprazan hydrochlorideCAS: 178307-42-1
Revaprazan Hydrochloride (YH1885) is a new reversible proton pump inhibitor with long-lasting acid-suppressive effects. Revaprazan Hydrochloride reversibly inhibits H(+)/K(+)-ATPase via binding to the K+-binding site of the pump.
COX - N-(4-acetamidophenyl)-Indomethacin amideCAS: 261766-23-8
Potent and selective reversible inhibitor of COX-2
COX
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC17980 | N-(2-phenylethyl)-Indomethacin amide | 261766-32-9 | COX | ||
A selective, reversible inhibitor of COX-2 | |||||
| GC36314 | Indobufen | 63610-08-2 | COX | ||
Indobufen (Ibustrin, K 3920) is a reversible platelet aggregation inhibitor. Indobufen is a reversible inhibitor of platelet cyclooxygenase (Cox) activity and suppresses thromboxane synthesis. | |||||
| GC15959 | N-(3-pyridyl)-Indomethacin amide | 261766-29-4 | COX | ||
Potent and selective reversible inhibitor of COX-2 | |||||
| GC38198 | Revaprazan hydrochloride | 178307-42-1 | COX | ||
Revaprazan Hydrochloride (YH1885) is a new reversible proton pump inhibitor with long-lasting acid-suppressive effects. Revaprazan Hydrochloride reversibly inhibits H(+)/K(+)-ATPase via binding to the K+-binding site of the pump. | |||||
| GC10611 | N-(4-acetamidophenyl)-Indomethacin amide | 261766-23-8 | COX | ||
Potent and selective reversible inhibitor of COX-2 | |||||